Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Achaogen Announces Executive Moves | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Achaogen Announces Executive Moves

The two have contributed heavily in their original roles to Achaogen's success

By: Betsy Louda

, Contract Pharma

Achaogen, Inc. has announced that Blake Wise, currently the company’s president and chief operating officer, will become chief executive officer effective January 1, 2018. He will also be joining Achaogen’s board of directors.

 

Kenneth Hillan, the company’s current chief executive officer, will move on to the newly created role of president of R&D, and president of Achaogen overall. Dr. Hillan will remain on the company’s board of directors.

 

“Achaogen is preparing for approval of its first drug, plazomicin, and Blake’s experience scaling and leading commercial organizations is perfectly suited to maximizing this stage of growth, and value, of the Company. At the same time, we are extremely fortunate to have Kenneth in a role that fully leverages his passion and success at the intersection of preclinical research and clinical drug development,” said Bryan Roberts, chairman of Achaogen’s Board of Directors and a partner at the venture capital firm Venrock.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters